Kozo Kuribayashi

Integrative Molecular Characterization of Malignant Pleural Mesothelioma

Julija Hmeljak, Francisco Sánchez-Vega, Katherine A. Hoadley et al. · Cancer Discovery · 2018 · 618 citations · Full text

Medicine, Oncology, Pathology +17

Circulating Tumor Cell as a Diagnostic Marker in Primary Lung Cancer

Fumihiro Tanaka, Kazue Yoneda, Nobuyuki Kondo et al. · Clinical Cancer Research · 2009 · 340 citations

Medicine, Clinical Sciences, Oncology +17

The Absence of Interleukin 1 Receptor–Related T1/St2 Does Not Affect T Helper Cell Type 2 Development and Its Effector Function

Katsuaki Hoshino, Shin‐ichiro Kashiwamura, Kozo Kuribayashi et al. · The Journal of Experimental Medicine · 1999 · 196 citations · Full text

Life Sciences, Cell Biology, Immunology +17

Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial

Giorgio V. Scagliotti, Rabab Gaafar, Anna K. Nowak et al. · The Lancet Respiratory Medicine · 2019 · 167 citations

Medicine, Oncology, Pharmacology +10

Efficacy and safety of pembrolizumab in patients with advanced mesothelioma in the open-label, single-arm, phase 2 KEYNOTE-158 study

Timothy A. Yap, Kazuhiko Nakagawa, Nobukazu Fujimoto et al. · The Lancet Respiratory Medicine · 2021 · 78 citations

Medicine, Oncology, Pharmacology +10